Focusing chronic oxaliplatin treatment of CRC cells, this therapy resulted in phenotypic changes associated with cellular plasticity, such as loss of polarity, spindle shape, and increase in mobility of these cells along with a decrease in E-cadherin expression and an increase in the expression of Snail and vimentin. The gene discussed is CDH1; the disease is colorectal carcinoma.